Location History:
- Dossenheim, DE (2011 - 2018)
- Heidelberg, DE (2021 - 2023)
Company Filing History:
9 out of 155 
6 out of 378 
5 out of 12,160 
Years Active: 2011-2023
Title: Michael Platten: Innovator in Cancer Treatment
Introduction
Michael Platten is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapeutic compounds. With a total of 12 patents to his name, Platten's work focuses on advancing medical science and improving patient outcomes.
Latest Patents
Among his latest patents, Platten has developed 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer. This invention encompasses compounds that are designed to target and treat various forms of cancer, particularly those associated with dysregulated immune responses. Additionally, he has created histone anti-cancer vaccines that utilize novel immunogenic peptide sequences aimed at treating brain cancers, specifically glioma. These vaccines are based on the K27M mutated variant of human Histone 3 and are designed to elicit a robust immune response against cancer cells.
Career Highlights
Throughout his career, Michael Platten has worked with esteemed organizations such as the Deutsches Krebsforschungszentrum and Bayer Pharma Aktiengesellschaft. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in oncology.
Collaborations
Platten has collaborated with notable colleagues, including Ilona Gutcher and Lars Röse. These partnerships have further enhanced his research efforts and have been instrumental in the development of his innovative cancer treatments.
Conclusion
Michael Platten's contributions to cancer research and treatment exemplify the impact of innovation in medicine. His patents and collaborative efforts continue to pave the way for advancements in therapeutic options for patients battling cancer.